Literature DB >> 8716526

Validating assessment of neonatal jaundice with transcutaneous bilirubin measurement.

P L Ruchala, L Seibold, K Stremsterfer.   

Abstract

In response to current trends in maternity care, nurses are assuming a major role in providing quality care for new mothers and their babies postdischarge through follow-up home care. Jaundice has been identified as the most commonly encountered cause of morbidity among healthy infants during the first week of life, and nurses must possess accurate neonatal assessment skills. Unlike nurses who work in hospital settings, those who provide home care do not have ready access to colleagues for consultation and validation of assessments. The result of unrefined assessment skills of nurses may be requests for unnecessary invasive procedures for infants and, consequently, monetary charges to patients for unnecessary lab work. A quasi-experimental design was used to determine whether the use of a jaundice meter to validate nurses' visual assessments would help them develop more accurate assessments of neonatal jaundice. Findings revealed high correlations between visual scale rankings of jaundice and jaundice meter readings (RS = .85, p < .01). The results of this pilot study indicate that the use of a jaundice meter may be a noninvasive as well as a cost-effective way to validate nurses' visual assessments of neonatal jaundice in the home.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8716526

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  2 in total

1.  Estimation of bilirubin using BiliChektrade mark, a transcutaneous bilirubin measurement device: Effects of gestational age and use of phototherapy.

Authors:  Ka Jangaard; H Curtis; Rb Goldbloom
Journal:  Paediatr Child Health       Date:  2006-02       Impact factor: 2.253

2.  Prediction of significant hyperbilirubinemia in term neonates by early non-invasive bilirubin measurement.

Authors:  Manish Jain; Akash Bang; Anju Tiwari; Shuchi Jain
Journal:  World J Pediatr       Date:  2016-11-23       Impact factor: 2.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.